Statin use is associated with a decreased risk of Barrett's esophagus

Gastroenterology

Volumn 147, Issue 2, 2014, Pages 314-323

  Nguyen, Theresa ^a,b   Khalaf, Natalia ^b   Ramsey, David ^a   El Serag, Hashem B ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Epidemiology; HMG CoA Reductase; Obesity; Pharmacoepidemiology; Risk Factors; Simvastatin; Veterans Affairs

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; EZETIMIBE; FENOFIBRATE; FLUINDOSTATIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CASE CONTROL STUDY; COLONOSCOPY; CONTROLLED STUDY; DRUG USE; ELECTIVE SURGERY; ELECTRONIC MEDICAL RECORD; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; TREATMENT DURATION; VETERAN;

EPIDEMIOLOGY; HMG-COA REDUCTASE; OBESITY; PHARMACOEPIDEMIOLOGY; RISK FACTORS; SIMVASTATIN; VETERANS AFFAIRS;

AGED; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; DRUG PRESCRIPTIONS; DYSLIPIDEMIAS; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84904733643     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.04.040     Document Type: Article

References (25)

1. A. Jemal, F. Bray, and M. Center et al. Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. M.B. Cook, W.-H. Chow, and S.S. Devesa Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005 Br J Cancer 101 2009 855 859
3. A. Dubecz, I. Gall, and N. Solymosi et al. Temporal trends in long-term survival and cure rates in esophageal cancer J Thorac Oncol 7 2012 443 447
4. M.F. Demierre, P.D. Higgins, and S.B. Gruber et al. Statins and cancer prevention Nat Rev Cancer 5 2005 930 942
5. P.C. Konturek, G. Burnat, and E.G. Hahn Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins J Physiol Pharmacol 58 2007 141 148
6. M.R. Sadaria, A.E. Reppert, and J.A. Yu et al. Statin therapy attenuates growth and malignant potential of human esophageal adenocarcinoma cells J Thorac Cardiovasc Surg 142 2011 1152 1160
7. F. Ye, G.H. Zhang, and B.X. Guan et al. Suppression of esophageal cancer cell growth using curcumin, (-)- epigallocatechin-3-gallate and lovastatin World J Gastroenterol 18 2012 126 135
8. O.O. Ogunwobi, and I.L. Beales Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells Am J Gastroenterol 103 2008 825 837
9. S. Singh, A.G. Singh, and P.P. Singh et al. Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis Clin Gastroenterol Hepatol 11 2013 620 629
10. M. Pera Trends in incidence and prevalence of specialized intestinal metaplasia, Barrett's esophagus, and adenocarcinoma of the gastroesophageal junction World J Surg 27 2003 999 1008
11. M.B. Cook, C.P. Wild, and S.M. Everett et al. Risk of mortality and cancer incidence in Barrett's esophagus Cancer Epidemiol Biomarkers Prev 16 2007 2090 2096
12. J. Ronkainen, P. Aro, and T. Storskrubb et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study Gastroenterology 129 2005 1825 1831
13. M. Solaymani-Dodaran, R.F.A. Logan, and J. West et al. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux Gut 53 2004 1070 1074
14. Z.B. Omer, A.N. Ananthakrishnan, and K.J. Nattinger et al. Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis Clin Gastroenterol Hepatol 10 2012 722 727
15. J.R. Kramer, L.A. Fischbach, and P. Richardson et al. Waist to hip ratio but not body mass index is associated with increased risk of Barrett's esophagus in white men Clin Gastroenterol Hepatol 11 2013 373 381.e1
16. P. Sharma, J. Dent, and D. Armstrong et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria Gastroenterology 131 2006 1392 1399
17. J.F. Steiner, T.D. Koepsell, and S.D. Fihn et al. A general method of compliance assessment using centralized pharmacy records. Description and validation Med Care 26 1988 814 823
18. C.M. Kozma, M. Dickson, and A.L. Phillips et al. Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis Patient Prefer Adherence 7 2013 509 516
19. P. Ilanne-Parikka, J.G. Eriksson, and J. Lindstrom et al. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort Diabetes Care 27 2004 2135 2140
20. M.J. Pencina, A.M. Navar-Boggan, and R.B. D'Agostino et al. Application of new cholesterol guidelines to a population-based sample N Engl J Med 370 2014 1422 1431
21. S. Rao, D.C. Porter, and X. Chen et al. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethylglutaryl-CoA reductase Proc Natl Acad Sci U S A 96 1999 7797-1802
22. W.W.-L. Wong, J. Dimitroulakos, and M.D. Minden et al. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 2002 508 519
23. L.M. Blanco-Colio, A. Villa, and M. Ortego et al. 3-Hydroxy-3-methyl- glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation Atherosclerosis 161 2002 17 26
24. R.O. Morgan, L.A. Petersen, and J.C. Hasche et al. VHA pharmacy use in veterans with Medicare drug coverage Am J Manag Care 15 2009 e1 e8
25. M. Lindblad, L.A. Rodriguez, and J. Lagergren Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study Cancer Causes Control 16 2005 285 294